Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Novo makes a rare disease push
EP Vantage
Wed, 03/9/22 - 10:42 am
Tags:
Novo Nordisk, rare disease
Novo Nordisk, citing strong Wegovy demand, doubles 2025 sales target for obesity franchise
Fierce Pharma
Thu, 03/3/22 - 10:54 am
Tags:
Novo Nordisk, obesity, Wegovy, Saxenda
Novo Nordisk gets NICE okay for obesity drug Wegovy
Pharmaforum
Tue, 02/8/22 - 09:55 am
Tags:
Novo Nordisk, Wegovy, UK, NICE, obesity
Novo Nordisk's Wegovy, hamstrung by Catalent FDA write-up, could correct course by mid-2022: analysts
Fierce Pharma
Thu, 01/27/22 - 10:47 am
Tags:
Novo Nordisk, Catalent, Wegovy, obesity, FDA
The top 10 biopharma M&A deals in 2021
Fierce Pharma
Tue, 01/18/22 - 10:53 am
Tags:
M&A, CSL, Vifor, Jazz Pharmaeuticals, GW Pharma, Novo Nordisk, Dicerna, Horizon Therapeutics, Viela Bio, Perrigo, HRA Pharma, Sanofi, Kadmon, Merck, Acceleron, Pfizer, Arena Pharmaceuticals, Translate Bio, Trillium Therapeutics, Amgen, Five Prime Therapeutics
Inside the Catalent FDA citation said to trigger Novo Nordisk's Wegovy supply hiccup
Fierce Pharma
Tue, 01/18/22 - 10:49 am
Tags:
Catalent, FDA, Novo Nordisk, Wegovy, supply chain
Novo Nordisk comes out clean in $1.8B investor lawsuit alleging insulin misdirection
Fierce Pharma
Mon, 01/17/22 - 10:55 am
Tags:
Novo Nordisk, investors, legal, insulin, diabetes
Novo Nordisk moves to strengthen obesity efforts
Pharmaforum
Mon, 01/17/22 - 10:27 am
Tags:
Novo Nordisk, obesity, EraCal Therapeutics
Biotech investors pray for a takeover miracle
EP Vantage
Fri, 01/14/22 - 11:09 am
Tags:
M&A, biotech, Amylyx Pharmaceuticals, Arena Pharmaceuticals, AstraZeneca, Aurinia Pharmaceuticals, Biogen, Biohaven, Bristol Myers Squibb, Eli Lilly, GSK, Merck, Novartis, Novo Nordisk, Pfizer, Sanofi
Biopharma’s stock market winners of 2021 revealed
EP Vantage
Wed, 01/12/22 - 10:50 am
Tags:
biotech stocks, Eli Lilly, Pfizer, Abbott Labs, Moderna Therapeutics, Merck KGaA, Novo Nordisk, BioNTech, Biohaven, Prothena, Bicycle Therapeutics, Bellus Health, Evolus
Novo Nordisk's weight loss drug Wegovy to run short amid contract manufacturer hiccup
Fierce Pharma
Mon, 12/20/21 - 10:50 am
Tags:
Novo Nordisk, Wegovy, obesity, drug manufacturing, drug shortages
Novo Nordisk, underway with key launches, reveals $2.58B manufacturing investment
Fierce Pharma
Mon, 12/13/21 - 11:50 pm
Tags:
Novo Nordisk, Denmark, drug manufacturing
Novo Nordisk, Sanofi and Eli Lilly cut insulin prices and lose share in China's latest cost squeeze
Fierce Pharma
Mon, 11/29/21 - 10:55 pm
Tags:
Novo Nordisk, Sanofi, Eli Lilly, insulin, China, diabetes, drug pricing
China’s insulin plans will hit 2022 revenues, says Novo Nordisk
Pharmaforum
Fri, 11/26/21 - 08:54 pm
Tags:
Novo Nordisk, China, insulin, diabetes, value-based procurement
Novo Nordisk bets big on RNAi, paying $3.3B to buy Dicerna
Fierce Biotech
Thu, 11/18/21 - 10:54 am
Tags:
Novo Nordisk, M&A, Dicerna Pharmaceuticals, RNAi
Novo Nordisk nears EU approval of obesity drug Wegovy
Pharmaforum
Fri, 11/12/21 - 10:34 am
Tags:
Novo Nordisk, Wegovy, obesity, Europe
Mixed court decisions for Novartis in DC and Sanofi, Novo Nordisk in NJ further complicate whose interpretation of 340B is correct
Endpoints
Mon, 11/8/21 - 10:46 am
Tags:
legal, drug discounts, 340B, Medicare, Sanofi, Novartis, Novo Nordisk
Demand for new obesity drug outstripping supply
Beckers Hospital Review
Wed, 11/3/21 - 11:29 pm
Tags:
Novo Nordisk, Wegovy, obesity
Judge rules HHS' letter enforcing 340B discounts was 'arbitrary'
Beckers Hospital Review
Tue, 11/2/21 - 11:51 pm
Tags:
HHS, drug pricing, 340B, AstraZeneca, Eli Lilly, Novo Nordisk, Sanofi, United Therapeutics
Novo Nordisk teams with CVS Health on obesity support program ahead of Wegovy DTC launch
Fierce Pharma
Tue, 10/19/21 - 10:50 am
Tags:
Novo Nordisk, obesity, Wegovy, pharma marketing, drug launches, CVS Health

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.